Recall archive / FDA food enforcement
Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405... — FDA record H-0447-2025
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jun 24, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9
- Reason
- Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.
- Classification
- Class III
- Recalling firm
- GMP Laboratories of America Inc
- Quantity
- ~185,482 capsules
- Agency-reported status
- Terminated
- Source record identifier
- H-0447-2025
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | 2.5mg Lot #: 21822 Expire date: 09/2026 10mg Lot#: 21108; 22649 Expire date: 10/2025; 01/2028 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Distribution was to a single customer who received product in California and Oklahoma.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Aug 20, 2025
- Recall initiation date
- Jun 24, 2025
- Center classification date
- Aug 8, 2025
- Termination date
- Feb 24, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.